What does CRO insurance cost?

CRO insurance program cost depends on revenue scale, trial phase mix, EU site exposure, cyber dataset size, and the underlying study sponsor base (innovator pharma vs generic vs investigator-sponsored). A clinical CRO in the $5 million to $50 million revenue range typically runs $45,000 to $180,000 per year for the full stack: professional liability/E&O, cyber, general liability, automobile, workers compensation at statutory limits, and umbrella.

The largest cost drivers are (1) trial phase mix - CROs supporting Phase 3 oncology and gene therapy place materially higher than CROs supporting Phase 1 single-ascending-dose studies, (2) EU site exposure - CROs supporting EU sites require GDPR-aligned cyber and EU clinical trial liability extensions, (3) cyber dataset size - measured by total subject PHI under management, not by CRO headcount, and (4) sponsor mix - CROs supporting public-biotech sponsors place higher because securities-class-action defense costs allocate downstream.

Pre-clinical CROs (bioanalytical, GLP toxicology, in vitro/in vivo screening) generally place at the lower end of the range because the regulatory framework is GLP rather than GCP and the data is animal subject data. The trade-off is cGLP-aligned property and validation losses that drive property and BI placement.